Composite primary endpoint: a stratagem of endpoint selection for heart failure randomized clinical trial
ESC Heart Failure · 04.07.2026 · 13 (4)
DOI: 10.1093/eschf/xvag188 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift ESC Heart Failure, online erschienen am 02.07.2026. Verfasst von Xu Duan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hangzhou First People's Hospital, 261# Huansha Road, Hangzhou 310006, China. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Xu Duan, Chao-feng Chen; Composite Primary Endpoint: A Stratagem of Endpoint Selection for Heart Failure Randomized Clinical Trial, ESC Heart Failure, , xv
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Hangzhou First People's Hospital, 261# Huansha Road, Hangzhou 310006, China.
- Department of Cardiology, Zhongshan Hospital Fudan University, Shanghai, China.
ORCID-Profile: Xu Duan
Zitieren
APA
Duan, X., & Chen, C. F. (2026). Composite primary endpoint: a stratagem of endpoint selection for heart failure randomized clinical trial. ESC Heart Failure, 13(4). https://doi.org/10.1093/eschf/xvag188
Vancouver
Duan X, Chen CF. Composite primary endpoint: a stratagem of endpoint selection for heart failure randomized clinical trial. ESC Heart Failure. 2026;13(4). doi:10.1093/eschf/xvag188
BibTeX
@article{Duan2026,
author = {Duan, Xu and Chen, Chao-Feng},
title = {Composite primary endpoint: a stratagem of endpoint selection for heart failure randomized clinical trial},
journal = {ESC Heart Failure},
year = {2026},
volume = {13},
number = {4},
doi = {10.1093/eschf/xvag188}
}
EUVIMED